The 20 Best Neuroendocrine Tumor Doctors Near Me in baltimore, MD

Ana De Jesus-Acosta is an Oncologist practicing medicine in Baltimore, Maryland. Dr. De Jesus-Acosta is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. De Jesus-Acosta is board certified in American Board Of Internal Medicine. Dr. De Jesus-Acosta is currently accepting new patients.

Elliot Fishman is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Fishman is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Angiosarcoma of the Liver, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fishman is board certified in American Board Of Radiology. Dr. Fishman is currently accepting new patients.

Kelly Lafaro is a Surgical Oncologist practicing medicine in Baltimore, Maryland. Dr. Lafaro is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Lafaro is board certified in American Board Of Surgery. Dr. Lafaro is currently accepting new patients.

Jin He is a General Surgeon and a Surgical Oncologist practicing medicine in Baltimore, Maryland. Dr. He is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Small Bowel Resection. Dr. He is board certified in American Board Of Surgery. Dr. He is currently accepting new patients.

Richard Burkhart is a Surgical Oncologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 18 years. Dr. Burkhart is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Burkhart is board certified in American Board Of Surgery. Dr. Burkhart is currently accepting new patients.

Ross Donehower is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Donehower is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Donehower is board certified in American Board Of Internal Medicine. Dr. Donehower is currently accepting new patients.

Dung Le is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Le is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer. Dr. Le is board certified in American Board Of Internal Medicine. Dr. Le is currently accepting new patients.

William Burns-Iii is a General Surgeon and a Surgical Oncologist practicing medicine in Baltimore, Maryland. Dr. Burns-Iii is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Familial Pancreatic Cancer, Familial Colorectal Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Burns-Iii is board certified in American Board Of Surgery. Dr. Burns-Iii is currently accepting new patients.

Satomi Kawamoto is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Kawamoto is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Muscle Invasive Bladder Cancer, Pancreatic Ductal Adenocarcinoma, Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy. Dr. Kawamoto is board certified in American Board Of Radiology. Dr. Kawamoto is currently accepting new patients.

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine. Dr. Hann is currently accepting new patients.

Taofeek Owonikoko is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, and Melanoma of the Eye. Dr. Lipson is board certified in American Board Of Internal Medicine. Dr. Lipson is currently accepting new patients.

John Cameron is a General Surgeon and a Surgical Oncologist practicing medicine in Baltimore, Maryland. Dr. Cameron is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Cameron is board certified in American Board Of Thoracic Surgery and American Board Of Surgery. Dr. Cameron is currently accepting new patients.

Nilo Azad is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Azad is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy. Dr. Azad is board certified in American Board Of Internal Medicine. Dr. Azad is currently accepting new patients.

Petr Hausner is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Hausner is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, and Melanoma. Dr. Hausner is board certified in American Board Of Internal Medicine - Medical Oncology, 1998. Dr. Hausner is currently accepting new patients.

Amir Hamrahian is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Hamrahian is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Cushing's disease, Pituitary Tumor, Cushing's syndrome, Prolactinoma, and Gamma Knife Radiosurgery. Dr. Hamrahian is board certified in American Board Of Internal Medicine. Dr. Hamrahian is currently accepting new patients.

Suzanne Topalian is a Surgical Oncologist practicing medicine in Baltimore, Maryland. Dr. Topalian is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Squamous Cell Carcinoma of the Anal Canal (SCAC).

Linda Chu is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Chu is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Chu is board certified in American Board Of Radiology. Dr. Chu is currently accepting new patients.

Shivani Ahlawat is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Ahlawat is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Schwannomatosis, Neurofibromatosis, Neurofibromatosis Type 1 (NF1), and Neurofibromatosis Type 2 (NF2). Dr. Ahlawat is board certified in American Board Of Radiology. Dr. Ahlawat is currently accepting new patients.

Pamela Johnson is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Renal Cell Carcinoma (RCC), Ampullary Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Johnson is board certified in American Board Of Radiology. Dr. Johnson is currently accepting new patients.